News coverage about perimenopause and menopause often focuses on midlife symptoms such as hot flashes, poor sleep and brain fog. A new observational study in JAMA Network Open examines what may happen once those symptoms fade.
Researchers followed 2,603 older women enrolled in the long-running Religious Orders Study and Rush Memory and Aging Project. They found that earlier menopause was associated with a slightly faster cognitive decline decades later. These women were also diagnosed with Alzheimer’s disease at younger ages. Among women whose menopause occurred naturally, earlier transition ages were associated with a faster buildup of white matter hyperintensities — bright spots on brain MRIs that can reflect small-vessel damage.
The data show a clear pattern, but they do not establish cause and effect.
Why this matters
Women account for nearly two-thirds of people with Alzheimer’s disease, while the hormone therapy market is booming with claims that research like this does not support.
The findings raise several questions reporters can ask:
- How are clinicians in your community distinguishing perimenopausal brain fog from dementia risk? Are patients being dismissed, or are routine symptoms sometimes being misinterpreted?
- What does midlife cardiovascular care look like for women locally? Are clinicians connecting reproductive history with long-term brain risk?
- What are local OB-GYNs telling patients about hormone therapy and cognitive protection? As AHCJ previously reported, only 20% of OB-GYN residencies offer menopause training, leaving many practitioners ill-equipped to parse conflicting evidence.
- Who enters menopause early in your community? Surgical menopause, autoimmune conditions and chemotherapy can all carry independent risks and may overlap with disparities in race, income and access to care.
- How are researchers and clinicians communicating uncertainty to patients, and how does that shape medical decision-making?
Brain fog vs. dementia
Research from the Study of Women’s Health Across the Nation suggests that temporary cognitive shifts around midlife are different from neurodegenerative disease. In this study, annual cognitive testing showed that earlier menopause was linked to less favorable cognitive trajectories over time. The clearest finding from the brain scans involved white matter hyperintensities. Over 10 years, women with natural menopause who transitioned five years earlier accumulated 15% more lesions than their peers. Still, going through menopause in one’s early 40s does not automatically mean dementia lies ahead.
White matter changes become more common with age and are linked with vascular health, including blood pressure, blood sugar, cholesterol, smoking and physical activity. Earlier menopause does not damage the brain on its own. Instead, it may signal the need to take a closer look at long-term cardiovascular health, the study’s authors suggested. The association could reflect lifetime hormone exposure, genetics, autoimmune disorders, chemotherapy or preexisting vascular problems. Surgical menopause adds more variables: ovary removal often occurs because of medical conditions that may carry independent risks.
No single fix
The JAMA study findings also do not justify claims that hormone therapy prevents dementia. As the Lancet Commission on Dementia Prevention, Intervention, and Care has emphasized, long-term cognitive health reflects multiple modifiable risk factors—from cardiovascular health and hearing loss to sleep, physical activity, depression and social connection—rather than a single solution.
Dementia risk builds over decades. Menopause timing is one variable, alongside blood-pressure control, hearing loss, sleep habits, physical activity and social connections.
Whether hormone therapy affects cognitive decline is still uncertain. Some studies find an association suggesting possible benefit in particular circumstances; others caution that the picture is more complicated. It also may depend on the type of menopause, the formulation and timing of menopausal hormone therapy, and a patient’s age and health when treatment begins.
Reporters can investigate whether women’s reproductive histories, vascular risks and cognitive concerns are being taken seriously — and if patients are receiving evidence-based information rather than promises of a one-size-fits-all fix.
Resources
- The Menopause Society
- The Menopause Hub, Black Women’s Health Initiative
- Menopause is Fueling a Movement, Ms. Magazine (2024)
- International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause, Climateric (2025)
- Menopause Resource Guides Aim to Create Menopause-Friendly Workplaces for All, Society for Women’s Health Research
